LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $66.46 million. The enterprise value is $66.97 million.
| Market Cap | 66.46M |
| Enterprise Value | 66.97M |
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Mar 2, 2026 |
Share Statistics
LifeVantage has 12.80 million shares outstanding. The number of shares has decreased by -1.45% in one year.
| Current Share Class | 12.80M |
| Shares Outstanding | 12.80M |
| Shares Change (YoY) | -1.45% |
| Shares Change (QoQ) | -1.55% |
| Owned by Insiders (%) | 21.54% |
| Owned by Institutions (%) | 55.37% |
| Float | 8.37M |
Valuation Ratios
The trailing PE ratio is 8.63 and the forward PE ratio is 8.85.
| PE Ratio | 8.63 |
| Forward PE | 8.85 |
| PS Ratio | 0.32 |
| Forward PS | 0.34 |
| PB Ratio | 2.01 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | 39.21 |
| P/OCF Ratio | 17.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.69, with an EV/FCF ratio of 39.51.
| EV / Earnings | 8.52 |
| EV / Sales | 0.32 |
| EV / EBITDA | 5.69 |
| EV / EBIT | 7.56 |
| EV / FCF | 39.51 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.03 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 6.31 |
| Interest Coverage | 196.82 |
Financial Efficiency
Return on equity (ROE) is 25.00% and return on invested capital (ROIC) is 23.14%.
| Return on Equity (ROE) | 25.00% |
| Return on Assets (ROA) | 8.54% |
| Return on Invested Capital (ROIC) | 23.14% |
| Return on Capital Employed (ROCE) | 21.01% |
| Weighted Average Cost of Capital (WACC) | 5.57% |
| Revenue Per Employee | $882,550 |
| Profits Per Employee | $33,025 |
| Employee Count | 238 |
| Asset Turnover | 3.24 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, LifeVantage has paid $1.43 million in taxes.
| Income Tax | 1.43M |
| Effective Tax Rate | 15.40% |
Stock Price Statistics
The stock price has decreased by -57.67% in the last 52 weeks. The beta is 0.39, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -57.67% |
| 50-Day Moving Average | 4.67 |
| 200-Day Moving Average | 7.88 |
| Relative Strength Index (RSI) | 61.12 |
| Average Volume (20 Days) | 187,548 |
Short Selling Information
The latest short interest is 3.75 million, so 29.26% of the outstanding shares have been sold short.
| Short Interest | 3.75M |
| Short Previous Month | 3.70M |
| Short % of Shares Out | 29.26% |
| Short % of Float | 44.74% |
| Short Ratio (days to cover) | 39.63 |
Income Statement
In the last 12 months, LifeVantage had revenue of $210.05 million and earned $7.86 million in profits. Earnings per share was $0.60.
| Revenue | 210.05M |
| Gross Profit | 165.40M |
| Operating Income | 8.86M |
| Pretax Income | 9.29M |
| Net Income | 7.86M |
| EBITDA | 11.77M |
| EBIT | 8.86M |
| Earnings Per Share (EPS) | $0.60 |
Balance Sheet
The company has $10.18 million in cash and $10.69 million in debt, giving a net cash position of -$510,000 or -$0.04 per share.
| Cash & Cash Equivalents | 10.18M |
| Total Debt | 10.69M |
| Net Cash | -510,000 |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | 32.99M |
| Book Value Per Share | 2.58 |
| Working Capital | 19.54M |
Cash Flow
In the last 12 months, operating cash flow was $3.75 million and capital expenditures -$2.05 million, giving a free cash flow of $1.70 million.
| Operating Cash Flow | 3.75M |
| Capital Expenditures | -2.05M |
| Depreciation & Amortization | 2.92M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.70M |
| FCF Per Share | $0.13 |
Margins
Gross margin is 78.75%, with operating and profit margins of 4.22% and 3.74%.
| Gross Margin | 78.75% |
| Operating Margin | 4.22% |
| Pretax Margin | 4.42% |
| Profit Margin | 3.74% |
| EBITDA Margin | 5.60% |
| EBIT Margin | 4.22% |
| FCF Margin | 0.81% |
Dividends & Yields
This stock pays an annual dividend of $0.18, which amounts to a dividend yield of 3.27%.
| Dividend Per Share | $0.18 |
| Dividend Yield | 3.27% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 29.93% |
| Buyback Yield | 1.45% |
| Shareholder Yield | 4.92% |
| Earnings Yield | 11.83% |
| FCF Yield | 2.55% |
Analyst Forecast
The average price target for LifeVantage is $11.00, which is 111.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 111.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 1:7.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
LifeVantage has an Altman Z-Score of 5.37 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.37 |
| Piotroski F-Score | 5 |